Leqembi, currently priced at $26,500 per year, could drive up Medicare costs by $5 billion per year if the FDA fully approves it.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,